Aileron Therapeutics, Inc. (ALRN) Financials
Stock symbol ALRN is outdated, potentially delisted? Maybe it is available on other exchange?
ALRN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 12.8 million | 1.6 million |
| June 30, 2023 | 14.0 million | 1.2 million |
| March 31, 2023 | 17.2 million | 2.9 million |
| Dec. 31, 2022 | 22.0 million | 3.4 million |
ALRN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -1.6 million | 229000 |
| June 30, 2023 | -3.1 million | 300000 |
| March 31, 2023 | -4.7 million | 391000 |
| Dec. 31, 2022 | -4.4 million | 424000 |
ALRN Net Income
No data available :(
ALRN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 12.1 million | - | - |
| June 30, 2023 | 13.7 million | - | - |
| March 31, 2023 | 16.7 million | - | - |
| Dec. 31, 2022 | 21.2 million | - | 33000 |
ALRN Shares Outstanding
ALRN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | - | 22000 | 2.0 million | - |
| June 30, 2023 | - | 187000 | 1.9 million | - |
| March 31, 2023 | - | 1.8 million | 2.2 million | - |
| Dec. 31, 2022 | - | 2.4 million | 2.3 million | - |
ALRN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | - | 12000 |
| June 30, 2023 | - | 12000 |
| March 31, 2023 | - | 43000 |
| Dec. 31, 2022 | - | 43000 |
ALRN
Price: $2.11
52 week price:
Earnings Per Share: -2.88 USD
P/E Ratio: -1.64
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 28786
Ebitda: -6.4 millionMarket Capitalization: 41.8 million